Lifeline Biotechnologies Market Cap

Lifeline Biotechnologies has a market cap or net worth of $4.35 thousand as of April 29, 2025. Its market cap has decreased by -99.68% in one year.

Market Cap

4.35K

Enterprise Value

n/a

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since December 31, 2003, Lifeline Biotechnologies's market cap has decreased from 18.97M to 4.35K, a decrease of -99.98%. That is a compound annual growth rate of -32.49%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2025	4.35K	-99.00%
Dec 31, 2024	434.89K	-35.07%
Dec 28, 2023	669.78K	-33.33%
Dec 30, 2022	1.00M	50.00%
Dec 31, 2021	669.78K	-60.00%
Dec 31, 2020	1.67M	-37.50%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.63B
Nika Pharmaceuticals	1.02B
Veradigm	746.57M
Glass House Brands	500.84M
Elite Pharmaceuticals	450.22M
Northwest Biotherapeutics	443.51M
CytoDyn	284.32M
BioStem Technologies	245.41M

Market Cap Rankings